Avid Bioservices Inc (CDMO) - Long-Term Debt to Capital Coefficient

Avid Bioservices, Inc. (CDMO) ensures the production of complex biomedicines, minimizing supply chain disruptions by distributing synthetic capacities, which supports high margins. The visual price representation on the page featuring the 4.78 metric complements data on the outsourcing model, where external IT platforms free up resources for core production. Meanwhile, technological barriers provide a certain level of pricing power, although declining biotech investment necessitates a flexible pricing policy.

Avid Bioservices, Inc. (CDMO) operates in the capital-intensive CDMO sector, where maintaining bioreactors requires significant investment. The ratio correlates long-term liabilities with equity, determining the degree of financial leverage during capacity expansion. This metric measures the company's reliance on borrowed funds with maturities exceeding one year. A decrease in the indicator signals deleveraging or a conservative approach to growth. Current long-term debt-to-equity price action reflects the balance between credit load and operational efficiency.